None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Children aged 7 to 18 years who can understand instructions and perform reliable spirometry 2.Both boys and girls included 3.Group A: Obese children defined by BMI above the 90th percentile for boys and above the 95th percentile for girls based on revised growth charts 4.Group B: Normal-weight healthy children defined by BMI between the 10th and 71st percentile for boys and between the 10th and 75th percentile for girls based on revised growth charts. 5.Written informed consent from parent or guardian and assent from the child where applicable. 6.Children able to cooperate and perform acceptable and repeatable pulmonary function tests according to ATS and ERS spirometry criteria.
Exclusion criteria
Exclusion criteria: 1.Recent acute respiratory infection or febrile illness within the past four weeks. 2.Known chronic respiratory disease or active wheeze requiring regular inhaled therapy. 3.Significant cardiac disease affecting respiration or exercise tolerance. 4.Neuromuscular disorders or major chest or skeletal deformities impairing spirometry. 5.Recent use of systemic corticosteroids or bronchodilators that may affect lung function. 6.Any condition interfering with participation, safety, or result interpretation. 7.Inability or refusal to provide consent or assent or to perform reproducible spirometry.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study is to establish the correlation of Katiparinah (waist circumference in angula) and Body Adiposity Index with pulmonary function test in obese and normal weight children. The findings may help in the early screening of children through katiparinah and BAI who are at risk of reduced lung function due to excess body fat, allowing timely interventions to improve respiratory health. The outcome will be assessed at the end of the completion of registration of samplesTimepoint: Not applicable, as the study is observational and result will be assessed at the end of study after completion of registration of all the samples. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
ch. brahm prakash ayurveda charak sansthan